Estimated 340B Revenue Exceeded Charity Care Spending for 85% of DSH Hospitals, Says Pharma-backed Group

340B revenue exceeds charity care spending for most DSH hospitals, said a report from drug industry-backed AIR340B.
Eighty-five percent of DSH hospitals earned more in estimated 340B revenue in 2022 than they incurred in charity care costs, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Three 340B Terminations, Seven Paybacks to Manufacturers in Latest Provider Audit Findings

Federal regulators released a March 20 update to ongoing 340B program integrity audits for fiscal year 2023.
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Judge Dismisses Health System’s Penny Pricing Coordination Lawsuit Against Drugmakers

A federal district judge has dismissed Calif.-based Adventist West's lawsuit against four drug manufacturers.
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate, House Appropriators Agree on Budget for Office of Pharmacy Affairs but Have Different Priorities

Senate and House appropriators have agreed on funding for HHS and the office within it that oversees 340B, but they appear to have different regulatory priorities.
While it appears that Senate and House appropriators have agreed on a funding level for the office that oversees the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Ballot Initiative Targets Big 340B Provider Serving HIV Population

Tom Myers, general counsel for AHF, said a California ballot measure is intended as retaliation against the HIV/AIDS group.
A California ballot initiative aims to codify the California governor’s 2019 shift of the Medicaid program’s prescription drug benefit from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Hospitals’ Low-Income Prostate Cancer Patients Had Better Adherence

Dr. Kassem Faraj and his co-authors at the University of Michigan found 340B was associated with better treatment adherence for more vulnerable prostate cancer patients.
Although 340B participation did not correlate to the start of costly treatment for men with advanced prostate cancer enrolled in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Small Share of Drugmaker Revenue, Says Hospital-Backed Report

340B drug discounts only amounted to a small percentage of total drugmaker revenue, a hospital-funded study found.
Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.C. Berkeley Researcher Proposes 340B Be Limited to the Indigent or that Providers Pass on their Discounts to Insurance Industry

Dr. James Robinson, a health economist at University of California at Berkley, criticized hospitals’ “buy and bill” drug acquisition process.
A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Long-Awaited Federal Bill to Protect Contract Pharmacy Arrangements Introduced

Doris Matsui
Rep. Doris Matsui (D-Calif.) introduced federal legislation to prohibit drugmaker 340B contract pharmacy restrictions.
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Is Thirty-first Company to Implement Contract Pharmacy Restrictions

Genentech building
Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.
Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live